文献速递前列腺癌

英格兰高危局限或局部晚期前列腺癌根治性局部治疗差异的决定因素

Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2021-09-07

基于英格兰国家前列腺癌审计数据库2014–2017年128家医院53,888例高危局限或局部晚期前列腺癌患者,65.0%接受根治性局部治疗。年轻、较富裕、合并症较少及非黑人种族背景者接受治疗的可能性更高,≥80岁患者医院间差异最大(ICC 0.235)。

要点

  • 年龄是根治性局部治疗最强的预测因素,年轻患者更可能接受治疗。
  • 较富裕、合并症较少及非黑人种族背景与更高的治疗可能性相关。
  • 医院间差异在≥80岁患者中最大(ICC 0.235),合并症和社会经济剥夺不影响医院间差异。

核心结论

  • 高危局限或局部晚期前列腺癌的根治性局部治疗强烈取决于年龄和合并症,也受社会经济剥夺和种族影响。
  • 医院间治疗差异在老年患者中最高。

研究设计与样本

  • 基于英格兰国家前列腺癌审计(NPCA)数据库的回顾性队列研究。
  • 纳入2014年1月至2017年12月128家医院的53,888例高危局限或局部晚期前列腺癌患者。
  • 使用漏斗图可视化医院间根治性局部治疗差异,并以随机截距多变量逻辑回归模型的组内相关系数(ICC)量化医院间差异。

主要发现

  • 53,888例患者中35,034例(65.0%)接受了根治性局部治疗。
  • 接受根治性局部治疗的可能性在较年轻(最强预测因素)、较富裕、合并症较少及非黑人种族背景的男性中增加。
  • ≥80岁患者的医院间差异(ICC:0.235)大于75–79岁(ICC:0.070)、70–74岁(ICC:0.041)和<70岁(ICC:0.048)患者,P < 0.001。
  • 合并症和社会经济剥夺不影响医院间差异。

临床怎么用

  • 临床决策中应关注年龄、合并症、社会经济剥夺和种族对根治性局部治疗可及性的影响。
  • 尤其对≥80岁患者,需注意医院间治疗差异,促进公平决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many factors are implicated in the potential 'under-treatment' of prostate cancer but little is known about the between-hospital variation. METHODS: The National Prostate Cancer Audit (NPCA) database was used to identify high-risk localised or locally advanced prostate cancer patients in England, between January 2014 and December 2017, and the treatments received. Hospital-level variation in radical local treatment was explored visually using funnel plots. The intra-class correlation coefficient (ICC) quantified the between-hospital variation in a random-intercept multivariable logistic regression model. RESULTS: 53,888 men, from 128 hospitals, were included and 35,034 (65.0%) received radical local treatment. The likelihood of receiving radical local treatment was increased in men who were younger (the strongest predictor), more affluent, those with fewer comorbidities, and in those with a non-Black ethnic background. There was more between-hospital variation (P < 0.001) for patients aged ≥80 years (ICC: 0.235) compared to patients aged 75-79 years (ICC: 0.070), 70-74 years (ICC: 0.041), and <70 years (ICC: 0.048). Comorbidity and socioeconomic deprivation did not influence the between-hospital variation. CONCLUSIONS: Radical local treatment of high-risk localised or locally advanced prostate cancer depended strongly on age and comorbidity, but also on socioeconomic deprivation and ethnicity, with the between-hospital variation being highest in older patients.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Parry MG, Boyle JM, Nossiter J, et al. Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England. Prostate Cancer Prostatic Dis. 2021. PMID: 34493837. doi:10.1038/s41391-021-00439-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。